Certainly, SMN2 deletion involves a limited albeit defined quote of the population (about 8-9% in [11]) and its significance is not clarified, since it has been proposed either as a protective factor [11], a noninfluent factor [23, 24], or as a risk factor for developing ALS [9, 25]. Here, SMN2 is linked to amyotrophic lateral sclerosis.